Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) EBIT Margin (2017 - 2025)

Historic EBIT Margin for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to 19.63%.

  • Neuronetics' EBIT Margin rose 220800.0% to 19.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.16%, marking a year-over-year increase of 86900.0%. This contributed to the annual value of 46.15% for FY2024, which is 33300.0% down from last year.
  • Latest data reveals that Neuronetics reported EBIT Margin of 19.63% as of Q3 2025, which was up 220800.0% from 21.15% recorded in Q2 2025.
  • In the past 5 years, Neuronetics' EBIT Margin ranged from a high of 19.63% in Q3 2025 and a low of 71.47% during Q1 2022
  • Moreover, its 5-year median value for EBIT Margin was 45.99% (2021), whereas its average is 45.03%.
  • Examining YoY changes over the last 5 years, Neuronetics' EBIT Margin showed a top increase of 341000bps in 2021 and a maximum decrease of -325700bps in 2021.
  • Over the past 5 years, Neuronetics' EBIT Margin (Quarter) stood at 45.99% in 2021, then rose by 8bps to 42.46% in 2022, then skyrocketed by 49bps to 21.79% in 2023, then tumbled by -134bps to 51.0% in 2024, then surged by 62bps to 19.63% in 2025.
  • Its EBIT Margin stands at 19.63% for Q3 2025, versus 21.15% for Q2 2025 and 34.45% for Q1 2025.